Search - tctmd.com

Displaying 241 - 260 of 806

Sort: Relevancy | Date

Presentation TCT 2017

BioFreedom: LEADERS FREE Long-term Results and LEADERS FREE II Design

Presenter: Mitchell W. Krucoff, Chaim S. Lotan, Philip M. Urban

November 01, 2017

Presentation TCT 2017

Polymer-Free Drug-Filled Stent and Updated REVELUTION Results

Presenter: Mitchell W. Krucoff, Chaim S. Lotan, Stephen G. Worthley

November 01, 2017

Presentation TCT 2017

Defining the High Bleeding Risk Patient: Consensus and Knowledge Gaps

Presenter: Mitchell W. Krucoff, Chaim S. Lotan, Marie-Claude Morice

November 01, 2017

Presentation TCT 2017

Theoretical Beneficial Effects of Eliminating the Polymer From DES: From Mechanical Issues to Biocompatibility

Presenter: Mitchell W. Krucoff, Chaim S. Lotan, Renu Virmani

November 01, 2017

Presentation TCT 2017

Left Main Case(s) #2: I Did Not Imagine This Case Would Require Two Stents!

Presenter: Kenneth Chin, Nicholas J. Lembo, Goran Stankovic

October 31, 2017

Presentation TCT 2017

Is There a Role for Dedicated Stents for the Left Main Bifurcation? Rationale and Device Landscape (With Case Examples)

Presenter: David Hildick-Smith, Jeffrey W. Moses, Carlo Briguori

October 31, 2017

Presentation TCT 2017

Coronary Stents for Left Main PCI: Considerations on Design and Selection, With Bench Examples

Presenter: David Hildick-Smith, Jeffrey W. Moses, Nicolas Foin

October 31, 2017

Presentation TCT 2017

Firehawk Sirolimus-Eluting Stent: Device Specifications and Clinical Program Update

Presenter: Manel Sabate, Joanna J. Wykrzykowska, Qi Zhang

October 31, 2017

Presentation TCT 2017

Buma Stent: Device Specifications, Clinical Trial Results, and Global Development

Presenter: Manel Sabate, Joanna J. Wykrzykowska, Kefei Dou

October 31, 2017

Presentation TCT 2017

Abluminus Sirolimus-Eluting Stent: Specifications and Clinical Development

Presenter: Manel Sabate, Joanna J. Wykrzykowska, Luca Testa

October 31, 2017

Presentation TCT 2017

The DESyne Novolimus-Eluting Coronary Stent: Results From the Excella Trials

Presenter: Manel Sabate, Joanna J. Wykrzykowska, Javaid Iqbal

October 31, 2017

Presentation TCT 2017

Outcomes With a Thin-Strut PLLA-Based Sirolimus-Eluting Stent 2: Inspiron

Presenter: Manel Sabate, Joanna J. Wykrzykowska, Pedro A. Lemos

October 31, 2017

Presentation TCT 2017

Outcomes With a Thin-Strut PLLA-Based Sirolimus-Eluting Stent 1: Biomime

Presenter: Manel Sabate, Joanna J. Wykrzykowska, Roberto Botelho

October 31, 2017

Presentation TCT 2017

The Combo Stent: From Concept to Clinical Performance

Presenter: Manel Sabate, Joanna J. Wykrzykowska, Roxana Mehran

October 31, 2017

Presentation TCT 2017

Optimal Technique: Radial vs Femoral Access, and Optimizing Patency With Covered vs Bare Metal Stents

Presenter: D. Christopher Metzger, Ido Weinberg

October 31, 2017

Presentation TCT 2017

TCT 58: Biomechanics and Drug Elution in Arterial Response to Peripheral Stents: A Comparative Study of 3 Contemporary Stents in Balloon-Predilated Femoral Arteries of Familial Hypercholesterolemic Swine

Presenter: Sahil A. Parikh, Yanping Cheng, MD

October 31, 2017

Presentation TCT 2017

Case #2 Introduction: 85-Year-Old Patient With Previous Stents and Severe Aortic Stenosis, Reduced LVEF, Chronic Anemia, and Mild Renal Impairment Develops Atrial Fibrillation After TAVR

Presenter: Nick Curzen, Rod H. Stables

October 31, 2017

Presentation TCT 2017

DCB Preclinical Perspectives: Mechanisms and Experimental Safety and Efficacy of Older, Current, and Futuristic DCB

Presenter: Robert A. Byrne, Ran Kornowski, Juan F. Granada

October 30, 2017

$Treatment of Refractory In-Stent Restenosis State-of-the-Art Review: From Standard Approaches to Parental Drugs and Vascular Brachytherapy$

Presentation TCT 2017

Treatment of Refractory In-Stent Restenosis State-of-the-Art Review: From Standard Approaches to Parental Drugs and Vascular Brachytherapy

Presenter: Robert A. Byrne, Ran Kornowski, Ron Waksman

October 30, 2017

Presentation TCT 2017

Treatment of First-time In-Stent Restenosis State-of-the-Art Review: From Lesion Preparation and Imaging to Restenting to DCB

Presenter: Robert A. Byrne, Ran Kornowski, Fernando Alfonso

October 30, 2017

Advertisement

BioFreedom: LEADERS FREE Long-term Results and LEADERS FREE II Design

Polymer-Free Drug-Filled Stent and Updated REVELUTION Results

Defining the High Bleeding Risk Patient: Consensus and Knowledge Gaps

Theoretical Beneficial Effects of Eliminating the Polymer From DES: From Mechanical Issues to Biocompatibility

Left Main Case(s) #2: I Did Not Imagine This Case Would Require Two Stents!

Is There a Role for Dedicated Stents for the Left Main Bifurcation? Rationale and Device Landscape (With Case Examples)

Coronary Stents for Left Main PCI: Considerations on Design and Selection, With Bench Examples

Firehawk Sirolimus-Eluting Stent: Device Specifications and Clinical Program Update

Buma Stent: Device Specifications, Clinical Trial Results, and Global Development

Abluminus Sirolimus-Eluting Stent: Specifications and Clinical Development

The DESyne Novolimus-Eluting Coronary Stent: Results From the Excella Trials

Outcomes With a Thin-Strut PLLA-Based Sirolimus-Eluting Stent 2: Inspiron

Outcomes With a Thin-Strut PLLA-Based Sirolimus-Eluting Stent 1: Biomime

The Combo Stent: From Concept to Clinical Performance

Optimal Technique: Radial vs Femoral Access, and Optimizing Patency With Covered vs Bare Metal Stents

TCT 58: Biomechanics and Drug Elution in Arterial Response to Peripheral Stents: A Comparative Study of 3 Contemporary Stents in Balloon-Predilated Femoral Arteries of Familial Hypercholesterolemic Swine

Case #2 Introduction: 85-Year-Old Patient With Previous Stents and Severe Aortic Stenosis, Reduced LVEF, Chronic Anemia, and Mild Renal Impairment Develops Atrial Fibrillation After TAVR

DCB Preclinical Perspectives: Mechanisms and Experimental Safety and Efficacy of Older, Current, and Futuristic DCB

Treatment of Refractory In-Stent Restenosis State-of-the-Art Review: From Standard Approaches to Parental Drugs and Vascular Brachytherapy

Treatment of First-time In-Stent Restenosis State-of-the-Art Review: From Lesion Preparation and Imaging to Restenting to DCB

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content